Heather Valerio is a PhD student in the Viral Hepatitis Clinical Research Program at the Kirby Institute.

Sofia Bartlett is a Postdoctoral Fellow at the BC Centre for Disease Control, working on the BC Hepatitis Testers Cohort. She is also a Non-Executive Director of the HepCBC Hepatitis Education and Prevention Society, and an Adjunct Associate Lecturer at the Kirby Institute, UNSW Sydney.

Maryam’s training and research is based in the field of epidemiology, with a specific focus on clinical epidemiology. She has a BSc in Biology and a MSc in Clinical Epidemiology. Maryam has completed her PhD in Epidemiology at UNSW Sydney, where she now is a Lecturer.

Prof. Catharina Matheï, MD,PhD (epidemiologist and addiction specialist) works at the Department of Public Health and Primary Care, KU Leuven and at the Free Clinic in Antwerp, an outpatient drug treatment center. Her domain of research concerns the epidemiology of infectious diseases. Her clinical and teaching activities involve addiction medicine.

I am an epidemiologist and hold an MSc. from the London School of Hygiene and Tropical Medicine. Within Public Health England, I currently work on the EPIToPE study (Evaluating the Population Impact of Hepatitis C Direct Acting Antiviral Treatment as Prevention for People Who Inject Drugs).

Alisa Pedrana is public health practitioner and senior research fellow at Burnet Institute. Her current work on Hepatitis C elimination is focussed on implementation science to strengthen health system, enhance health service delivery and develop sustainable models of care.

I am a second-year PhD candidate (Scientia Scholar) at the Kirby Institute, UNSW, Australia and a member of HIV/STI Surveillance Research Centre and the WHO Collaborating Centre for HIV in Iran. My research and expertise focus on infectious diseases surveillance and prevention, particularly STIs, HIV, and HCV.

Dr Doyle is an infectious diseases physician at the The Alfred and Monash University Department of Infectious Diseases

Annette Gaudino is the State and Local Policy Director at Treatment Action Group (TAG), where she works to advance hepatitis C, HIV and TB elimination across U.S. jurisdictions, with special attention to the needs of people who use drugs.